Supporting Initiatives to Redistribute Unused Medicine (SIRUM) – Trademark Portfolio
Entity Type: 03
Supporting Initiatives to Redistribute Unused Medicine (SIRUM) holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SIRUM. The owner is based in Palo Alto, CA.
3000 El Camino Real
Palo Alto, CA 94306
Showing of trademarks Trademarks
Trademark Classifications
Supporting Initiatives to Redistribute Unused Medicine (SIRUM)'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Supporting Initiatives to Redistribute Unused Medicine (SIRUM) have?
Supporting Initiatives to Redistribute Unused Medicine (SIRUM) has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Supporting Initiatives to Redistribute Unused Medicine (SIRUM) file in?
Supporting Initiatives to Redistribute Unused Medicine (SIRUM) files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.
What are Supporting Initiatives to Redistribute Unused Medicine (SIRUM)'s most well-known trademarks?
Supporting Initiatives to Redistribute Unused Medicine (SIRUM)'s registered trademark portfolio includes well-known marks such as SIRUM. These are among 1 currently registered trademark in the portfolio.
What is Supporting Initiatives to Redistribute Unused Medicine (SIRUM)'s trademark registration success rate?
Supporting Initiatives to Redistribute Unused Medicine (SIRUM) has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.